Document is current
Any future updates will be listed below
-
Authors
Godeluck, Anais
Gérardin, Patrick
Lenclume, Victorine
Mussard, Corinne
Robillard, Pierre-Yves
Sampériz, Sylvain
Benhammou, Valérie
Truffert, Patrick
Ancel, Pierre-Yves
Ramful, Duksha
-
Funding
Funding for this research was provided by:
The French Institute of Public Health Research/Institute of Public Health & Partner
Agence Régionale de Santé-Indian Ocean regional health agency
- License Information
-
More Information
Article History
Received: 15 May 2019
Accepted: 29 August 2019
First Online: 17 October 2019
Ethics approval and consent to participate
: The EPIPAGE-2 study was approved by the CNIL (CNIL n°911009) and by the appropriate ethics committees, i.e.<i>,</i> the advisory committee on the treatment of personal health data for research purposes (CCTIRS, approval granted November 18, 2010; reference number 10.626) and the CPP (approval granted March 18, 2011, reference CPP SC-2873). Families gave written informed consent to participate in the study after they had received both oral and written information. The OGP cohort was approved by the French national data protection authority (Comité National de l’Informatique et des Libertés, CNIL n°1250024). Families gave oral consent to participate in the cohort after they had received both oral and written information.
: Not applicable.
: The authors declare that they have no competing interests.
